Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
...
Health Technology » Biotechnology
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| AMGN | Amgen Inc. | 1.09% | 203.00 | 1.2% | $406.48m | |
| GILD | Gilead Sciences, Inc. | 0.51% | 73.15 | 0.9% | $396.47m | |
| CELG | Celgene Corporation | 0.67% | 87.78 | 1.2% | $341.39m | |
| BIIB | Biogen Inc. | 0.26% | 335.26 | 1.2% | $274.67m | |
| ILMN | Illumina, Inc. | 1.42% | 352.16 | 3.5% | $255.83m | |
| REGN | Regeneron Pharmaceuticals, Inc. | -0.14% | 385.97 | 2.6% | $209.96m | |
| EXAS | Exact Sciences Corporation | -1.79% | 72.02 | 25.3% | $195.13m | |
| VRTX | Vertex Pharmaceuticals Incorporated | 0.59% | 176.83 | 1.9% | $160.81m | |
| SRPT | Sarepta Therapeutics, Inc. | 0.79% | 153.56 | 16.4% | $125.86m | |
| A | Agilent Technologies, Inc. | -0.51% | 68.73 | 1.5% | $120.88m | |
| ALXN | Alexion Pharmaceuticals, Inc. | 1.59% | 119.68 | 2.0% | $109.20m | |
| NKTR | Nektar Therapeutics | 0.50% | 58.60 | 5.6% | $96.44m | |
| ALNY | Alnylam Pharmaceuticals, Inc | 0.42% | 93.75 | 9.7% | $96.22m | |
| BMRN | BioMarin Pharmaceutical Inc. | 1.00% | 99.13 | 4.4% | $91.59m | |
| INCY | Incyte Corporation | 0.73% | 67.51 | 2.5% | $88.35m |
Company Profile
Versartis, Inc. is an endocrine-focused biopharmaceutical company, which engages in the research and development of pharmaceutical products. Its portfolio includes Somavartan and XTEN TEchnology which target the endocrine disorders and growth hormone deficiencies. The company was founded by Jeffrey L. Cleland, Mark de Boer, Willem Stemmer, Volker Schellenberger, and Joshua Silverman on December 10, 2008 and is headquartered in Menlo Park, CA.